Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block

Nature Immunology

Volumn 7, Issue 10, 2006, Pages 1048-1056

  Kirstetter, Peggy ^a   Anderson, Kristina ^b   Porse, Bo T ^c   Jacobsen, Sten Eirik W ^b   Nerlov, Claus ^a,b  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; INTEGRIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BMI 1; TRANSCRIPTION FACTOR HOXB4; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL LOSS; CELL POPULATION; CONTROLLED STUDY; EMBRYO; ERYTHROCYTE; ERYTHROID CELL; GENE EXPRESSION; GENETIC CODE; GRANULOCYTE; HEMATOPOIETIC STEM CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINEAGE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; INTEGRINS; MICE; MICE, MUTANT STRAINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 33748850636     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1381     Document Type: Article

References (55)

1. Logan, C.Y. & Nusse, R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810 (2004).
2. Giles, R.H., van Es, J.H. & Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1-24 (2003).
3. Muller-Tidow, C. et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol. Cell. Biol. 24, 2890-2904 (2004).
4. Lu, D. et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 101, 3118-3123 (2004).
5. Bauer, A. et al. Pontin52 and reptin52 function as antagonistic regulators of β-catenin signalling activity. EMBO J. 19, 6121-6130 (2000).
6. Austin, T.W., Solar, G.P., Ziegler, F.C., Liem, L. & Matthews, W. A role for the Wnt gene family in hematopoiesis: Expansion of multilineage progenitor cells. Blood 89, 3624-3635 (1997).
7. Van Den Berg, D.J., Sharma, A.K., Bruno, E. & Hoffman, R. Role of members of the Wnt gene family in human hematopoiesis. Blood 92, 3189-3202 (1998).
8. Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409-414 (2003).
9. Duncan A.W. et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Immunol. 6, 314-322 (2005).
10. Cobas, M. β-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 199, 221-229 (2004).
11. Reya, T., Okamura, R. & Grosschedl, R. Control of lymphocyte differentiation by the LEF-1/TCF family of transcription factors. Cold Spring Harb. Symp. Quant. Biol. 64, 133-140 (1999).
12. Okamura, R.M. et al. Redundant regulation of T cell differentiation and TCRa gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8, 11-20 (1998).
13. Xu, Y., Banerjee, D., Huelsken, J., Birchmeier, W. & Sen, J.M. Deletion of β-catenin impairs T cell development. Nat. Immunol. 4, 1177-1182 (2003).
14. Gounari, F. et al. Somatic activation of β-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development. Nat. Immunol. 2, 863-869 (2001).
15. + thymocyte survival. Nat. Immunol. 2, 691-697 (2001).
16. Kolligs, F.T., Hu, G., Dang, C.V. & Fearon, E.R. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/ Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19, 5696-5706 (1999).
17. Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547-558 (1999).
18. Higuchi, M. et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1, 63-74 (2002).
19. -/- mice due to decreased survival of early erythroblasts. Blood 98, 3261-3273 (2001).
20. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193-197 (2000).
21. Kondo, M., Weissman, I.L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661-672 (1997).
22. Hardy, R.R. & Hayakawa, K. B cell development pathways. Annu. Rev. Immunol. 19, 595-621 (2001).
23. Rickert, R.C., Roes, J. & Rajewsky, K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25, 1317-1318 (1997).
24. Allman, D. et al. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4, 168-174 (2003).
25. Lee, P.P. et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15, 763-774 (2001).
26. + stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15, 659-669 (2001).
27. - short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105, 2717-2723 (2005).
28. + lympho-myeloid stem cells lacking erythromegakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295-306 (2005).
29. Potocnik, A.J., Brakebusch, C. & Fassler, R. Fetal and adult hematopoietic stem cells require b1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity 12, 653-663 (2000).
30. Rekhtman, N., Radparvar, F., Evans, T. & Skoultchi, A.I. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 13, 1398-1411 (1999).
31. Nerlov, C. & Graf, T. P.U.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12, 2403-2412 (1998).
32. cip1/waf1. Science 287, 1804-1808 (2000).
33. Park, I.K. et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305 (2003).
34. Antonchuk, J., Sauvageau, G. & Humphries, R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109, 39-45 (2002).
35. Bouvard, D. et al. Functional consequences of integrin gene mutations in mice. Circ. Res. 89, 211-223 (2001).
36. + hematopoietic stem cells. Stem Cells 4, 1087-1094 (2006).
37. Domen, J., Cheshier, S.H. & Weissman, I.L. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191, 253-264 (2000).
38. Trowbridge, J.J., Xenocostas, A., Moon, R.T. & Bhatia, M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat. Med. 12, 89-98 (2006).
39. Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448-452 (2003).
40. Zhang, P. et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc. Natl. Acad. Sci. USA 96, 8705-8710 (1999).
41. Nerlov, C., Querfurth, E., Kulessa, H. & Graf, T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 95, 2543-2551 (2000).
42. Nutt, S.L., Metcalf, D., D'Amico, A., Polli, M. & Wu, L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 201, 221-231 (2005).
43. Reya, T. et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13, 15-24 (2000).
44. Bhandoola, A. & Sambandam, A. From stem cell to T cell: One route or many? Nat. Rev. Immunol. 6, 117-126 (2006).
45. Rosenbauer, F. et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38, 27-37 (2006).
46. Galceran, J., Farinas, I., Depew, M.J., Clevers, H. & Grosschedl, R. Wnt3a-/- like phenotype and limb deficiency in Lef1-/-Tcf1-/- mice. Genes Dev. 13, 709-717 (1999).
47. Angrand, P.O., Daigle, N., van der Hoeven, F., Scholer, H.R. & Stewart, A.F. Simplified generation of targeting constructs using ET recombination. Nucleic Acids Res. 27, e16 (1999).
48. Awatramani, R., Soriano, P., Mai, J.J. & Dymecki, S. An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus. Nat. Genet. 29, 257-259 (2001).
49. Porse, B.T. et al. E2F repression by C/EBPa is required for adipogenesis and granulopoiesis in vivo. Cell 107, 247-258 (2001).
50. Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081 (1995).
51. Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427-1429 (1995).
52. Kennell, J.A., O'Leary, E.E., Gummow, B.M., Hammer, G.D. & MacDougald, O.A. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with b-catenin to coactivate C/EBPa and steroidogenic factor 1 transcription factors. Mol. Cell. Biol. 23, 5366-5375 (2003).
53. Bryder, D. et al. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J. Exp. Med. 194, 941-952 (2001).
54. Hock, H. et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431, 1002-1007 (2004).
55. Porse, B.T. et al. Loss of C/EBPα cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J. Exp. Med. 202, 85-96 (2005).